Zentalis Pharmaceuticals, Inc.·4

Feb 4, 4:45 PM ET

Skvarka Jan 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 4, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
Skvarka Jan
Director
Transactions
  • Purchase

    Common Stock

    2025-01-31$1.72/sh+60,000$103,446149,551 total

Documents

1 file
  • 4
    wk-form4_1738705494.xmlPrimary

    FORM 4